nodes	percent_of_prediction	percent_of_DWPC	metapath
Amsacrine—TOP2A—Epirubicin—testicular cancer	0.224	0.319	CbGbCtD
Amsacrine—TOP2A—Etoposide—testicular cancer	0.175	0.248	CbGbCtD
Amsacrine—TOP2A—Doxorubicin—testicular cancer	0.119	0.169	CbGbCtD
Amsacrine—ABCB1—Dactinomycin—testicular cancer	0.0414	0.0589	CbGbCtD
Amsacrine—ABCB1—Vinblastine—testicular cancer	0.0259	0.0369	CbGbCtD
Amsacrine—CYP2D6—Vinblastine—testicular cancer	0.0244	0.0347	CbGbCtD
Amsacrine—ABCB1—Cisplatin—testicular cancer	0.0238	0.0338	CbGbCtD
Amsacrine—ABCB1—Etoposide—testicular cancer	0.0234	0.0332	CbGbCtD
Amsacrine—ABCB1—Doxorubicin—testicular cancer	0.0159	0.0227	CbGbCtD
Amsacrine—ABCB1—Methotrexate—testicular cancer	0.0154	0.0219	CbGbCtD
Amsacrine—CYP2D6—Doxorubicin—testicular cancer	0.015	0.0213	CbGbCtD
Amsacrine—NCOA3—Idarubicin—Epirubicin—testicular cancer	0.0018	0.241	CbGdCrCtD
Amsacrine—NCOA3—Idarubicin—Doxorubicin—testicular cancer	0.00167	0.223	CbGdCrCtD
Amsacrine—NCOA3—gonad—testicular cancer	0.00161	0.153	CbGeAlD
Amsacrine—NCOA3—female gonad—testicular cancer	0.00131	0.124	CbGeAlD
Amsacrine—NCOA3—testis—testicular cancer	0.00116	0.11	CbGeAlD
Amsacrine—NCOA3—lymph node—testicular cancer	0.000843	0.0797	CbGeAlD
Amsacrine—TOP2A—female gonad—testicular cancer	0.000769	0.0727	CbGeAlD
Amsacrine—TOP2A—Vindesine—Vinblastine—testicular cancer	0.000753	0.101	CbGdCrCtD
Amsacrine—KCNH2—seminal vesicle—testicular cancer	0.000734	0.0694	CbGeAlD
Amsacrine—TOP2A—testis—testicular cancer	0.000682	0.0645	CbGeAlD
Amsacrine—TOP2A—lymph node—testicular cancer	0.000494	0.0468	CbGeAlD
Amsacrine—TOP2A—Vinorelbine—Vinblastine—testicular cancer	0.000475	0.0635	CbGdCrCtD
Amsacrine—TOP2A—Teniposide—Etoposide—testicular cancer	0.000475	0.0634	CbGdCrCtD
Amsacrine—TOP2A—Podofilox—Etoposide—testicular cancer	0.000475	0.0634	CbGdCrCtD
Amsacrine—KCNH2—female gonad—testicular cancer	0.000431	0.0408	CbGeAlD
Amsacrine—TOP2A—Vincristine—Vinblastine—testicular cancer	0.000406	0.0543	CbGdCrCtD
Amsacrine—KCNH2—testis—testicular cancer	0.000382	0.0362	CbGeAlD
Amsacrine—ABCB1—embryo—testicular cancer	0.000343	0.0324	CbGeAlD
Amsacrine—ABCB1—seminal vesicle—testicular cancer	0.000322	0.0304	CbGeAlD
Amsacrine—KCNH2—lymph node—testicular cancer	0.000277	0.0262	CbGeAlD
Amsacrine—Pain—Ifosfamide—testicular cancer	0.000268	0.000961	CcSEcCtD
Amsacrine—Mood swings—Epirubicin—testicular cancer	0.000267	0.000959	CcSEcCtD
Amsacrine—Lethargy—Doxorubicin—testicular cancer	0.000266	0.000956	CcSEcCtD
Amsacrine—Thrombocytopenia—Cisplatin—testicular cancer	0.000264	0.000949	CcSEcCtD
Amsacrine—Blood creatinine increased—Epirubicin—testicular cancer	0.000264	0.000949	CcSEcCtD
Amsacrine—Tachycardia—Cisplatin—testicular cancer	0.000263	0.000946	CcSEcCtD
Amsacrine—Asthenia—Bleomycin—testicular cancer	0.000263	0.000944	CcSEcCtD
Amsacrine—CYP2D6—female gonad—testicular cancer	0.000263	0.0249	CbGeAlD
Amsacrine—Convulsion—Etoposide—testicular cancer	0.000262	0.000943	CcSEcCtD
Amsacrine—Skin disorder—Cisplatin—testicular cancer	0.000262	0.000941	CcSEcCtD
Amsacrine—Feeling abnormal—Ifosfamide—testicular cancer	0.000258	0.000926	CcSEcCtD
Amsacrine—Nausea—Vinblastine—testicular cancer	0.000258	0.000925	CcSEcCtD
Amsacrine—Anorexia—Cisplatin—testicular cancer	0.000257	0.000924	CcSEcCtD
Amsacrine—Affect lability—Doxorubicin—testicular cancer	0.000257	0.000922	CcSEcCtD
Amsacrine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—testicular cancer	0.000256	0.00092	CcSEcCtD
Amsacrine—Gastrointestinal pain—Ifosfamide—testicular cancer	0.000256	0.000919	CcSEcCtD
Amsacrine—Aspartate aminotransferase increased—Epirubicin—testicular cancer	0.000254	0.000912	CcSEcCtD
Amsacrine—Hypotension—Cisplatin—testicular cancer	0.000252	0.000906	CcSEcCtD
Amsacrine—Hypersensitivity—Dactinomycin—testicular cancer	0.000252	0.000904	CcSEcCtD
Amsacrine—Confusional state—Etoposide—testicular cancer	0.000249	0.000895	CcSEcCtD
Amsacrine—Urticaria—Ifosfamide—testicular cancer	0.000249	0.000893	CcSEcCtD
Amsacrine—TOP2A—Idarubicin—Epirubicin—testicular cancer	0.000248	0.0331	CbGdCrCtD
Amsacrine—TOP2A—Daunorubicin—Epirubicin—testicular cancer	0.000248	0.0331	CbGdCrCtD
Amsacrine—TOP2A—Doxorubicin—Epirubicin—testicular cancer	0.000248	0.0331	CbGdCrCtD
Amsacrine—Abdominal pain—Ifosfamide—testicular cancer	0.000247	0.000889	CcSEcCtD
Amsacrine—Body temperature increased—Ifosfamide—testicular cancer	0.000247	0.000889	CcSEcCtD
Amsacrine—Pancytopenia—Methotrexate—testicular cancer	0.000247	0.000888	CcSEcCtD
Amsacrine—Mood swings—Doxorubicin—testicular cancer	0.000247	0.000888	CcSEcCtD
Amsacrine—Infection—Etoposide—testicular cancer	0.000246	0.000882	CcSEcCtD
Amsacrine—Asthenia—Dactinomycin—testicular cancer	0.000245	0.00088	CcSEcCtD
Amsacrine—Blood creatinine increased—Doxorubicin—testicular cancer	0.000244	0.000878	CcSEcCtD
Amsacrine—Dysphagia—Epirubicin—testicular cancer	0.000244	0.000875	CcSEcCtD
Amsacrine—Paraesthesia—Cisplatin—testicular cancer	0.000242	0.00087	CcSEcCtD
Amsacrine—Thrombocytopenia—Etoposide—testicular cancer	0.000242	0.000869	CcSEcCtD
Amsacrine—Tachycardia—Etoposide—testicular cancer	0.000241	0.000866	CcSEcCtD
Amsacrine—Dyspnoea—Cisplatin—testicular cancer	0.000241	0.000864	CcSEcCtD
Amsacrine—Skin disorder—Etoposide—testicular cancer	0.00024	0.000862	CcSEcCtD
Amsacrine—Anorexia—Etoposide—testicular cancer	0.000236	0.000846	CcSEcCtD
Amsacrine—Aspartate aminotransferase increased—Doxorubicin—testicular cancer	0.000235	0.000844	CcSEcCtD
Amsacrine—Decreased appetite—Cisplatin—testicular cancer	0.000235	0.000842	CcSEcCtD
Amsacrine—Diarrhoea—Dactinomycin—testicular cancer	0.000234	0.000839	CcSEcCtD
Amsacrine—CYP2D6—testis—testicular cancer	0.000233	0.022	CbGeAlD
Amsacrine—Gastrointestinal disorder—Cisplatin—testicular cancer	0.000233	0.000837	CcSEcCtD
Amsacrine—Vomiting—Bleomycin—testicular cancer	0.000233	0.000836	CcSEcCtD
Amsacrine—ABCB1—gonad—testicular cancer	0.000233	0.022	CbGeAlD
Amsacrine—Infestation NOS—Methotrexate—testicular cancer	0.000232	0.000834	CcSEcCtD
Amsacrine—Infestation—Methotrexate—testicular cancer	0.000232	0.000834	CcSEcCtD
Amsacrine—Pancytopenia—Epirubicin—testicular cancer	0.000231	0.000831	CcSEcCtD
Amsacrine—Hypotension—Etoposide—testicular cancer	0.000231	0.00083	CcSEcCtD
Amsacrine—Rash—Bleomycin—testicular cancer	0.000231	0.000829	CcSEcCtD
Amsacrine—Pain—Cisplatin—testicular cancer	0.000231	0.000829	CcSEcCtD
Amsacrine—Dermatitis—Bleomycin—testicular cancer	0.000231	0.000829	CcSEcCtD
Amsacrine—Hypersensitivity—Ifosfamide—testicular cancer	0.000231	0.000828	CcSEcCtD
Amsacrine—TOP2A—Idarubicin—Doxorubicin—testicular cancer	0.000229	0.0306	CbGdCrCtD
Amsacrine—TOP2A—Epirubicin—Doxorubicin—testicular cancer	0.000229	0.0306	CbGdCrCtD
Amsacrine—TOP2A—Daunorubicin—Doxorubicin—testicular cancer	0.000229	0.0306	CbGdCrCtD
Amsacrine—Renal failure—Methotrexate—testicular cancer	0.000228	0.00082	CcSEcCtD
Amsacrine—Stomatitis—Methotrexate—testicular cancer	0.000226	0.000813	CcSEcCtD
Amsacrine—Dysphagia—Doxorubicin—testicular cancer	0.000225	0.00081	CcSEcCtD
Amsacrine—Asthenia—Ifosfamide—testicular cancer	0.000225	0.000806	CcSEcCtD
Amsacrine—Feeling abnormal—Cisplatin—testicular cancer	0.000222	0.000799	CcSEcCtD
Amsacrine—Paraesthesia—Etoposide—testicular cancer	0.000222	0.000797	CcSEcCtD
Amsacrine—Weight increased—Epirubicin—testicular cancer	0.000222	0.000796	CcSEcCtD
Amsacrine—Haematuria—Methotrexate—testicular cancer	0.000221	0.000795	CcSEcCtD
Amsacrine—Weight decreased—Epirubicin—testicular cancer	0.00022	0.000792	CcSEcCtD
Amsacrine—Dyspnoea—Etoposide—testicular cancer	0.00022	0.000792	CcSEcCtD
Amsacrine—Hepatobiliary disease—Methotrexate—testicular cancer	0.00022	0.000789	CcSEcCtD
Amsacrine—Nausea—Bleomycin—testicular cancer	0.000218	0.000781	CcSEcCtD
Amsacrine—Infestation NOS—Epirubicin—testicular cancer	0.000217	0.00078	CcSEcCtD
Amsacrine—Infestation—Epirubicin—testicular cancer	0.000217	0.00078	CcSEcCtD
Amsacrine—Vomiting—Dactinomycin—testicular cancer	0.000217	0.00078	CcSEcCtD
Amsacrine—Agranulocytosis—Methotrexate—testicular cancer	0.000217	0.000778	CcSEcCtD
Amsacrine—Rash—Dactinomycin—testicular cancer	0.000215	0.000773	CcSEcCtD
Amsacrine—Decreased appetite—Etoposide—testicular cancer	0.000215	0.000772	CcSEcCtD
Amsacrine—Diarrhoea—Ifosfamide—testicular cancer	0.000214	0.000769	CcSEcCtD
Amsacrine—Pancytopenia—Doxorubicin—testicular cancer	0.000214	0.000769	CcSEcCtD
Amsacrine—Renal failure—Epirubicin—testicular cancer	0.000214	0.000767	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Etoposide—testicular cancer	0.000213	0.000766	CcSEcCtD
Amsacrine—Body temperature increased—Cisplatin—testicular cancer	0.000213	0.000766	CcSEcCtD
Amsacrine—Fatigue—Etoposide—testicular cancer	0.000213	0.000765	CcSEcCtD
Amsacrine—Jaundice—Epirubicin—testicular cancer	0.000212	0.000761	CcSEcCtD
Amsacrine—Stomatitis—Epirubicin—testicular cancer	0.000212	0.000761	CcSEcCtD
Amsacrine—Pain—Etoposide—testicular cancer	0.000211	0.000759	CcSEcCtD
Amsacrine—Haemoglobin—Methotrexate—testicular cancer	0.000209	0.000752	CcSEcCtD
Amsacrine—Hepatitis—Methotrexate—testicular cancer	0.000208	0.000748	CcSEcCtD
Amsacrine—Haemorrhage—Methotrexate—testicular cancer	0.000208	0.000748	CcSEcCtD
Amsacrine—Haematuria—Epirubicin—testicular cancer	0.000207	0.000744	CcSEcCtD
Amsacrine—Dizziness—Ifosfamide—testicular cancer	0.000207	0.000743	CcSEcCtD
Amsacrine—Urinary tract disorder—Methotrexate—testicular cancer	0.000206	0.000739	CcSEcCtD
Amsacrine—Hepatobiliary disease—Epirubicin—testicular cancer	0.000206	0.000738	CcSEcCtD
Amsacrine—Weight increased—Doxorubicin—testicular cancer	0.000205	0.000737	CcSEcCtD
Amsacrine—Urethral disorder—Methotrexate—testicular cancer	0.000204	0.000734	CcSEcCtD
Amsacrine—Weight decreased—Doxorubicin—testicular cancer	0.000204	0.000733	CcSEcCtD
Amsacrine—Feeling abnormal—Etoposide—testicular cancer	0.000204	0.000732	CcSEcCtD
Amsacrine—Nausea—Dactinomycin—testicular cancer	0.000203	0.000729	CcSEcCtD
Amsacrine—Agranulocytosis—Epirubicin—testicular cancer	0.000203	0.000728	CcSEcCtD
Amsacrine—Gastrointestinal pain—Etoposide—testicular cancer	0.000202	0.000726	CcSEcCtD
Amsacrine—Infestation NOS—Doxorubicin—testicular cancer	0.000201	0.000722	CcSEcCtD
Amsacrine—Infestation—Doxorubicin—testicular cancer	0.000201	0.000722	CcSEcCtD
Amsacrine—Vomiting—Ifosfamide—testicular cancer	0.000199	0.000715	CcSEcCtD
Amsacrine—Hypersensitivity—Cisplatin—testicular cancer	0.000199	0.000714	CcSEcCtD
Amsacrine—Bradycardia—Epirubicin—testicular cancer	0.000199	0.000713	CcSEcCtD
Amsacrine—Renal failure—Doxorubicin—testicular cancer	0.000198	0.00071	CcSEcCtD
Amsacrine—Rash—Ifosfamide—testicular cancer	0.000197	0.000709	CcSEcCtD
Amsacrine—Dermatitis—Ifosfamide—testicular cancer	0.000197	0.000708	CcSEcCtD
Amsacrine—Urticaria—Etoposide—testicular cancer	0.000196	0.000705	CcSEcCtD
Amsacrine—Haemoglobin—Epirubicin—testicular cancer	0.000196	0.000704	CcSEcCtD
Amsacrine—Stomatitis—Doxorubicin—testicular cancer	0.000196	0.000704	CcSEcCtD
Amsacrine—Jaundice—Doxorubicin—testicular cancer	0.000196	0.000704	CcSEcCtD
Amsacrine—Abdominal pain—Etoposide—testicular cancer	0.000195	0.000702	CcSEcCtD
Amsacrine—Body temperature increased—Etoposide—testicular cancer	0.000195	0.000702	CcSEcCtD
Amsacrine—Haemorrhage—Epirubicin—testicular cancer	0.000195	0.0007	CcSEcCtD
Amsacrine—Hepatitis—Epirubicin—testicular cancer	0.000195	0.0007	CcSEcCtD
Amsacrine—Hypoaesthesia—Epirubicin—testicular cancer	0.000194	0.000697	CcSEcCtD
Amsacrine—Asthenia—Cisplatin—testicular cancer	0.000194	0.000695	CcSEcCtD
Amsacrine—Cardiac disorder—Methotrexate—testicular cancer	0.000193	0.000695	CcSEcCtD
Amsacrine—Urinary tract disorder—Epirubicin—testicular cancer	0.000193	0.000692	CcSEcCtD
Amsacrine—Haematuria—Doxorubicin—testicular cancer	0.000192	0.000688	CcSEcCtD
Amsacrine—Connective tissue disorder—Epirubicin—testicular cancer	0.000192	0.000688	CcSEcCtD
Amsacrine—Urethral disorder—Epirubicin—testicular cancer	0.000191	0.000687	CcSEcCtD
Amsacrine—Hepatobiliary disease—Doxorubicin—testicular cancer	0.00019	0.000683	CcSEcCtD
Amsacrine—Angiopathy—Methotrexate—testicular cancer	0.000189	0.000679	CcSEcCtD
Amsacrine—ABCB1—female gonad—testicular cancer	0.000189	0.0179	CbGeAlD
Amsacrine—Mediastinal disorder—Methotrexate—testicular cancer	0.000188	0.000675	CcSEcCtD
Amsacrine—Agranulocytosis—Doxorubicin—testicular cancer	0.000188	0.000674	CcSEcCtD
Amsacrine—Nausea—Ifosfamide—testicular cancer	0.000186	0.000668	CcSEcCtD
Amsacrine—Diarrhoea—Cisplatin—testicular cancer	0.000185	0.000663	CcSEcCtD
Amsacrine—Alopecia—Methotrexate—testicular cancer	0.000184	0.000661	CcSEcCtD
Amsacrine—Bradycardia—Doxorubicin—testicular cancer	0.000184	0.00066	CcSEcCtD
Amsacrine—Mental disorder—Methotrexate—testicular cancer	0.000183	0.000656	CcSEcCtD
Amsacrine—Hypersensitivity—Etoposide—testicular cancer	0.000182	0.000654	CcSEcCtD
Amsacrine—Malnutrition—Methotrexate—testicular cancer	0.000181	0.000652	CcSEcCtD
Amsacrine—Haemoglobin—Doxorubicin—testicular cancer	0.000181	0.000651	CcSEcCtD
Amsacrine—Cardiac disorder—Epirubicin—testicular cancer	0.000181	0.00065	CcSEcCtD
Amsacrine—Hepatitis—Doxorubicin—testicular cancer	0.00018	0.000648	CcSEcCtD
Amsacrine—Haemorrhage—Doxorubicin—testicular cancer	0.00018	0.000648	CcSEcCtD
Amsacrine—Hypoaesthesia—Doxorubicin—testicular cancer	0.00018	0.000645	CcSEcCtD
Amsacrine—Urinary tract disorder—Doxorubicin—testicular cancer	0.000178	0.00064	CcSEcCtD
Amsacrine—Asthenia—Etoposide—testicular cancer	0.000177	0.000637	CcSEcCtD
Amsacrine—Connective tissue disorder—Doxorubicin—testicular cancer	0.000177	0.000637	CcSEcCtD
Amsacrine—Angiopathy—Epirubicin—testicular cancer	0.000177	0.000636	CcSEcCtD
Amsacrine—Urethral disorder—Doxorubicin—testicular cancer	0.000177	0.000635	CcSEcCtD
Amsacrine—Mediastinal disorder—Epirubicin—testicular cancer	0.000176	0.000631	CcSEcCtD
Amsacrine—Arrhythmia—Epirubicin—testicular cancer	0.000174	0.000626	CcSEcCtD
Amsacrine—Alopecia—Epirubicin—testicular cancer	0.000172	0.000619	CcSEcCtD
Amsacrine—Vomiting—Cisplatin—testicular cancer	0.000172	0.000616	CcSEcCtD
Amsacrine—Vision blurred—Methotrexate—testicular cancer	0.000171	0.000614	CcSEcCtD
Amsacrine—Mental disorder—Epirubicin—testicular cancer	0.000171	0.000614	CcSEcCtD
Amsacrine—Rash—Cisplatin—testicular cancer	0.00017	0.000611	CcSEcCtD
Amsacrine—Dermatitis—Cisplatin—testicular cancer	0.00017	0.00061	CcSEcCtD
Amsacrine—Malnutrition—Epirubicin—testicular cancer	0.00017	0.00061	CcSEcCtD
Amsacrine—Diarrhoea—Etoposide—testicular cancer	0.000169	0.000607	CcSEcCtD
Amsacrine—Anaemia—Methotrexate—testicular cancer	0.000168	0.000602	CcSEcCtD
Amsacrine—ABCB1—testis—testicular cancer	0.000168	0.0159	CbGeAlD
Amsacrine—Cardiac disorder—Doxorubicin—testicular cancer	0.000168	0.000602	CcSEcCtD
Amsacrine—Angiopathy—Doxorubicin—testicular cancer	0.000164	0.000588	CcSEcCtD
Amsacrine—Dizziness—Etoposide—testicular cancer	0.000163	0.000587	CcSEcCtD
Amsacrine—Mediastinal disorder—Doxorubicin—testicular cancer	0.000163	0.000584	CcSEcCtD
Amsacrine—Leukopenia—Methotrexate—testicular cancer	0.000162	0.000583	CcSEcCtD
Amsacrine—Arrhythmia—Doxorubicin—testicular cancer	0.000161	0.000579	CcSEcCtD
Amsacrine—Nausea—Cisplatin—testicular cancer	0.00016	0.000576	CcSEcCtD
Amsacrine—Vision blurred—Epirubicin—testicular cancer	0.00016	0.000575	CcSEcCtD
Amsacrine—Alopecia—Doxorubicin—testicular cancer	0.000159	0.000573	CcSEcCtD
Amsacrine—Mental disorder—Doxorubicin—testicular cancer	0.000158	0.000568	CcSEcCtD
Amsacrine—Convulsion—Methotrexate—testicular cancer	0.000157	0.000565	CcSEcCtD
Amsacrine—Vomiting—Etoposide—testicular cancer	0.000157	0.000564	CcSEcCtD
Amsacrine—Malnutrition—Doxorubicin—testicular cancer	0.000157	0.000564	CcSEcCtD
Amsacrine—Anaemia—Epirubicin—testicular cancer	0.000157	0.000564	CcSEcCtD
Amsacrine—Rash—Etoposide—testicular cancer	0.000156	0.00056	CcSEcCtD
Amsacrine—Dermatitis—Etoposide—testicular cancer	0.000156	0.000559	CcSEcCtD
Amsacrine—Headache—Etoposide—testicular cancer	0.000155	0.000556	CcSEcCtD
Amsacrine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000153	0.000551	CcSEcCtD
Amsacrine—Leukopenia—Epirubicin—testicular cancer	0.000152	0.000546	CcSEcCtD
Amsacrine—Confusional state—Methotrexate—testicular cancer	0.000149	0.000536	CcSEcCtD
Amsacrine—Vision blurred—Doxorubicin—testicular cancer	0.000148	0.000532	CcSEcCtD
Amsacrine—Convulsion—Epirubicin—testicular cancer	0.000147	0.000528	CcSEcCtD
Amsacrine—Infection—Methotrexate—testicular cancer	0.000147	0.000528	CcSEcCtD
Amsacrine—Nausea—Etoposide—testicular cancer	0.000147	0.000527	CcSEcCtD
Amsacrine—Anaemia—Doxorubicin—testicular cancer	0.000145	0.000521	CcSEcCtD
Amsacrine—Thrombocytopenia—Methotrexate—testicular cancer	0.000145	0.000521	CcSEcCtD
Amsacrine—Skin disorder—Methotrexate—testicular cancer	0.000144	0.000517	CcSEcCtD
Amsacrine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000144	0.000516	CcSEcCtD
Amsacrine—Anorexia—Methotrexate—testicular cancer	0.000141	0.000507	CcSEcCtD
Amsacrine—Leukopenia—Doxorubicin—testicular cancer	0.000141	0.000505	CcSEcCtD
Amsacrine—Confusional state—Epirubicin—testicular cancer	0.00014	0.000502	CcSEcCtD
Amsacrine—Hypotension—Methotrexate—testicular cancer	0.000138	0.000497	CcSEcCtD
Amsacrine—Infection—Epirubicin—testicular cancer	0.000138	0.000494	CcSEcCtD
Amsacrine—Convulsion—Doxorubicin—testicular cancer	0.000136	0.000489	CcSEcCtD
Amsacrine—Thrombocytopenia—Epirubicin—testicular cancer	0.000136	0.000487	CcSEcCtD
Amsacrine—Tachycardia—Epirubicin—testicular cancer	0.000135	0.000486	CcSEcCtD
Amsacrine—Skin disorder—Epirubicin—testicular cancer	0.000135	0.000483	CcSEcCtD
Amsacrine—Paraesthesia—Methotrexate—testicular cancer	0.000133	0.000478	CcSEcCtD
Amsacrine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000133	0.000477	CcSEcCtD
Amsacrine—Anorexia—Epirubicin—testicular cancer	0.000132	0.000474	CcSEcCtD
Amsacrine—Dyspnoea—Methotrexate—testicular cancer	0.000132	0.000474	CcSEcCtD
Amsacrine—Hypotension—Epirubicin—testicular cancer	0.000129	0.000465	CcSEcCtD
Amsacrine—Confusional state—Doxorubicin—testicular cancer	0.000129	0.000464	CcSEcCtD
Amsacrine—Decreased appetite—Methotrexate—testicular cancer	0.000129	0.000462	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000128	0.000459	CcSEcCtD
Amsacrine—Fatigue—Methotrexate—testicular cancer	0.000128	0.000458	CcSEcCtD
Amsacrine—Infection—Doxorubicin—testicular cancer	0.000127	0.000457	CcSEcCtD
Amsacrine—Pain—Methotrexate—testicular cancer	0.000127	0.000455	CcSEcCtD
Amsacrine—Thrombocytopenia—Doxorubicin—testicular cancer	0.000126	0.000451	CcSEcCtD
Amsacrine—Tachycardia—Doxorubicin—testicular cancer	0.000125	0.000449	CcSEcCtD
Amsacrine—Skin disorder—Doxorubicin—testicular cancer	0.000125	0.000447	CcSEcCtD
Amsacrine—Paraesthesia—Epirubicin—testicular cancer	0.000124	0.000447	CcSEcCtD
Amsacrine—Dyspnoea—Epirubicin—testicular cancer	0.000124	0.000444	CcSEcCtD
Amsacrine—Anorexia—Doxorubicin—testicular cancer	0.000122	0.000439	CcSEcCtD
Amsacrine—Feeling abnormal—Methotrexate—testicular cancer	0.000122	0.000438	CcSEcCtD
Amsacrine—ABCB1—lymph node—testicular cancer	0.000122	0.0115	CbGeAlD
Amsacrine—Gastrointestinal pain—Methotrexate—testicular cancer	0.000121	0.000435	CcSEcCtD
Amsacrine—Decreased appetite—Epirubicin—testicular cancer	0.00012	0.000433	CcSEcCtD
Amsacrine—Hypotension—Doxorubicin—testicular cancer	0.00012	0.00043	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Epirubicin—testicular cancer	0.00012	0.00043	CcSEcCtD
Amsacrine—Fatigue—Epirubicin—testicular cancer	0.000119	0.000429	CcSEcCtD
Amsacrine—Pain—Epirubicin—testicular cancer	0.000119	0.000426	CcSEcCtD
Amsacrine—Urticaria—Methotrexate—testicular cancer	0.000118	0.000422	CcSEcCtD
Amsacrine—Abdominal pain—Methotrexate—testicular cancer	0.000117	0.00042	CcSEcCtD
Amsacrine—Body temperature increased—Methotrexate—testicular cancer	0.000117	0.00042	CcSEcCtD
Amsacrine—Paraesthesia—Doxorubicin—testicular cancer	0.000115	0.000413	CcSEcCtD
Amsacrine—Dyspnoea—Doxorubicin—testicular cancer	0.000114	0.000411	CcSEcCtD
Amsacrine—Feeling abnormal—Epirubicin—testicular cancer	0.000114	0.00041	CcSEcCtD
Amsacrine—Gastrointestinal pain—Epirubicin—testicular cancer	0.000113	0.000407	CcSEcCtD
Amsacrine—Decreased appetite—Doxorubicin—testicular cancer	0.000111	0.0004	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000111	0.000398	CcSEcCtD
Amsacrine—Fatigue—Doxorubicin—testicular cancer	0.000111	0.000397	CcSEcCtD
Amsacrine—Urticaria—Epirubicin—testicular cancer	0.00011	0.000395	CcSEcCtD
Amsacrine—Pain—Doxorubicin—testicular cancer	0.00011	0.000394	CcSEcCtD
Amsacrine—Abdominal pain—Epirubicin—testicular cancer	0.00011	0.000393	CcSEcCtD
Amsacrine—Body temperature increased—Epirubicin—testicular cancer	0.00011	0.000393	CcSEcCtD
Amsacrine—Hypersensitivity—Methotrexate—testicular cancer	0.000109	0.000392	CcSEcCtD
Amsacrine—Asthenia—Methotrexate—testicular cancer	0.000106	0.000382	CcSEcCtD
Amsacrine—Feeling abnormal—Doxorubicin—testicular cancer	0.000106	0.000379	CcSEcCtD
Amsacrine—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000105	0.000377	CcSEcCtD
Amsacrine—Hypersensitivity—Epirubicin—testicular cancer	0.000102	0.000367	CcSEcCtD
Amsacrine—Urticaria—Doxorubicin—testicular cancer	0.000102	0.000366	CcSEcCtD
Amsacrine—Body temperature increased—Doxorubicin—testicular cancer	0.000101	0.000364	CcSEcCtD
Amsacrine—Abdominal pain—Doxorubicin—testicular cancer	0.000101	0.000364	CcSEcCtD
Amsacrine—Diarrhoea—Methotrexate—testicular cancer	0.000101	0.000364	CcSEcCtD
Amsacrine—Asthenia—Epirubicin—testicular cancer	9.94e-05	0.000357	CcSEcCtD
Amsacrine—Dizziness—Methotrexate—testicular cancer	9.79e-05	0.000352	CcSEcCtD
Amsacrine—Diarrhoea—Epirubicin—testicular cancer	9.48e-05	0.00034	CcSEcCtD
Amsacrine—Hypersensitivity—Doxorubicin—testicular cancer	9.45e-05	0.000339	CcSEcCtD
Amsacrine—Vomiting—Methotrexate—testicular cancer	9.42e-05	0.000338	CcSEcCtD
Amsacrine—Rash—Methotrexate—testicular cancer	9.34e-05	0.000335	CcSEcCtD
Amsacrine—Dermatitis—Methotrexate—testicular cancer	9.33e-05	0.000335	CcSEcCtD
Amsacrine—Headache—Methotrexate—testicular cancer	9.28e-05	0.000333	CcSEcCtD
Amsacrine—Asthenia—Doxorubicin—testicular cancer	9.2e-05	0.00033	CcSEcCtD
Amsacrine—Dizziness—Epirubicin—testicular cancer	9.16e-05	0.000329	CcSEcCtD
Amsacrine—Vomiting—Epirubicin—testicular cancer	8.81e-05	0.000316	CcSEcCtD
Amsacrine—Nausea—Methotrexate—testicular cancer	8.8e-05	0.000316	CcSEcCtD
Amsacrine—Diarrhoea—Doxorubicin—testicular cancer	8.77e-05	0.000315	CcSEcCtD
Amsacrine—Rash—Epirubicin—testicular cancer	8.74e-05	0.000314	CcSEcCtD
Amsacrine—Dermatitis—Epirubicin—testicular cancer	8.73e-05	0.000313	CcSEcCtD
Amsacrine—Headache—Epirubicin—testicular cancer	8.68e-05	0.000312	CcSEcCtD
Amsacrine—Dizziness—Doxorubicin—testicular cancer	8.48e-05	0.000304	CcSEcCtD
Amsacrine—Nausea—Epirubicin—testicular cancer	8.23e-05	0.000296	CcSEcCtD
Amsacrine—Vomiting—Doxorubicin—testicular cancer	8.15e-05	0.000293	CcSEcCtD
Amsacrine—Rash—Doxorubicin—testicular cancer	8.09e-05	0.00029	CcSEcCtD
Amsacrine—Dermatitis—Doxorubicin—testicular cancer	8.08e-05	0.00029	CcSEcCtD
Amsacrine—Headache—Doxorubicin—testicular cancer	8.03e-05	0.000288	CcSEcCtD
Amsacrine—Nausea—Doxorubicin—testicular cancer	7.62e-05	0.000274	CcSEcCtD
